SECRETORY LEUKOCYTE PROTEASE INHIBITOR - A MACROPHAGE PRODUCT INDUCEDBY AND ANTAGONISTIC TO BACTERIAL LIPOPOLYSACCHARIDE

Citation
Fy. Jin et al., SECRETORY LEUKOCYTE PROTEASE INHIBITOR - A MACROPHAGE PRODUCT INDUCEDBY AND ANTAGONISTIC TO BACTERIAL LIPOPOLYSACCHARIDE, Cell, 88(3), 1997, pp. 417-426
Citations number
68
Categorie Soggetti
Biology,"Cell Biology
Journal title
CellACNP
ISSN journal
00928674
Volume
88
Issue
3
Year of publication
1997
Pages
417 - 426
Database
ISI
SICI code
0092-8674(1997)88:3<417:SLPI-A>2.0.ZU;2-M
Abstract
To explore regulation of potentially lethal responses to bacterial lip opolysaccharide (LPS), we used differential display under LPS-free con ditions to compare macrophage cell lines from two strains of mice cong enic for a locus affecting LPS sensitivity. LPS-hyporesponsive cells, primary macrophages, and polymorphonuclear leukocytes transcribed secr etory leukocyte protease inhibitor (SLPI), a known epithelial cell-der ived inhibitor of leukocyte serine proteases. Transfection of macropha ges with SLPI suppressed LPS-induced activation of NF-kappa B and prod uction of nitric oxide and TNF alpha. The ability of interferon-gamma (IFN gamma) to restore LPS responsiveness is a hallmark of the LPS-hyp oresponsive phenotype. IFN gamma suppressed expression of SLPI and res tored LPS responsiveness to SLPI-producing cells. Thus, SLPI is an LPS -induced IFN gamma-suppressible phagocyte product that serves to inhib it LPS responses.